Alaunos Therapeutics (TCRT) FCF Margin Growth (3y) (2014 - 2025)
Alaunos Therapeutics (TCRT) FCF Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.53 Mn |
| Dec 31, 2024 | 89.03 Mn |
| Mar 31, 2018 | -950,831.00 |
| Dec 31, 2017 | 205,683.00 |
| Sep 30, 2017 | 87,188.00 |
| Jun 30, 2017 | 289,880.00 |
| Mar 31, 2017 | 340,509.00 |
| Dec 31, 2016 | 370,583.00 |
| Sep 30, 2016 | 703,167.00 |
| Jun 30, 2016 | 747,610.00 |
| Mar 31, 2016 | 816,792.00 |
| Dec 31, 2015 | 888,481.00 |
| Sep 30, 2015 | 995,941.00 |
| Jun 30, 2015 | 462,340.00 |
| Mar 31, 2015 | 936,282.00 |
| Dec 31, 2014 | 450,221.00 |
| Sep 30, 2014 | 335,730.00 |
| Jun 30, 2014 | -81,550.00 |
| Mar 31, 2014 | 820,686.00 |